Long-Term Thyroxine Administration Protects the Heart in a Pattern Similar to Ischemic Preconditioning
- 1 April 2002
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 12 (4) , 325-329
Abstract
We have previously shown that long-term thyroxine administration can protect the heart against ischemia. In the present study, we investigated whether thyroxine-induced cardioprotection can mimic the pattern of protection that is afforded by a well-established cardioprotective means such as ischemic preconditioning. In a Langendorff-perfused rat heart preparation, after an initial stabilization, normal and thyroxine-treated hearts were subjected to 20 minutes of zero-flow global ischemia followed by 45 minutes of reperfusion. In thyroxine-treated hearts, phospho-p38 mitogen-activated protein kinase (MAPK) was found to be less at the end of the ischemic period, whereas ischemic contracture was accelerated and postischemic recovery was increased in comparison to normal hearts. In addition, normal hearts were subjected to a four-cycle preconditioning protocol before ischemia. Phospho-p38 MAPK was found to be less at the end of the ischemic period in preconditioned hearts, whereas ischemic contracture was accelerated and postischemic functional recovery was increased in those hearts in comparison to nonpreconditioned hearts. An increase in basal expression and phosphorylation of PKCδ was also found to occur after long-term thyroxine administration. We conclude that long-term thyroxine administration can protect the heart from ischemic injury through a pattern of protection that closely resembles that of ischemic preconditioning.Keywords
This publication has 15 references indexed in Scilit:
- Long-term thyroxine administration increases heat stress protein-70 mRNA expression and attenuates p38 MAP kinase activity in response to ischaemiaJournal of Endocrinology, 2001
- Editorial: Thyroid Hormone--Targeting the HeartEndocrinology, 2001
- Propranolol Diminishes Cardiac Hypertrophy But Does Not Abolish Acceleration of the Ischemic Contracture in Hyperthyroid HeartsJournal of Cardiovascular Pharmacology, 2000
- Ischemic preconditioningPharmacology & Therapeutics, 2000
- Hyperthyroidism is associated with preserved preconditioning capacity but intensified and accelerated ischaemic contracture in rat heartBasic Research in Cardiology, 1999
- Inhibition of p38 Mitogen-Activated Protein Kinase Decreases Cardiomyocyte Apoptosis and Improves Cardiac Function After Myocardial Ischemia and ReperfusionCirculation, 1999
- An Inhibitor of p38 Mitogen-activated Protein Kinase Protects Neonatal Cardiac Myocytes from IschemiaJournal of Biological Chemistry, 1999
- Dichotomy of Ischemic PreconditioningCirculation, 1996
- Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemiaThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986